It is less than a week since I posted this, however, in the interim, there has been a report of two cases of reinfection. It is still not much when we consider the 26 million recorded infections, still, it needs to be considered. Read the summary at read the summary https://blogs.jwatch.org/hiv-id-observations/index.php/cases-of-sars-cov-2-reinfection-highlight-the-limitations-and-the-mysteries-of-our-immune-system/2020/08/30/?query=C19&cid=DM98059_NEJM_Registered_Users_and_InActive&bid=253773475
Even as an oral pathologist with no clinical worries of tooth cutting, aerosol contamination, and the like I am not untouched by the challenges that the dental profession is facing each day due to the increasing number of Covid-19 cases. Possibly like every other dentist, I have all the relevant updates delivered to my mailbox each day.
Yesterday an interesting one caught my eye, a letter to the
editor of NEJM “Saliva or
Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2” by Wyllie, Ann L., et al. They report findings of
their recent study on the effectiveness of the salivary sample in the diagnosis of
COVID- 19 infection. Significantly the study found saliva to be at the very
least as useful as nasopharyngeal swab specimens for quantitative reverse-
transcriptase PCR detection of Covid-19. The authors highlighted the importance
of saliva as the test sample, negating the need for trained personnel
involvement, and exposure.
From a dental viewpoint, it is noteworthy that :
- Asymptomatic patient’s saliva carried a recoverable number of virus copies.
- The overall virus count and percentage of cases where the virus could be recovered were higher in saliva than the nasopharyngeal swabs, up to 10 days after the infection.
- The salivary recovery of virus copies was more consistent throughout the clinical course of the disease.
The authors relate some of the
finding of higher salivary virus counts and overall recovery rates to the inherent
ease of salivary sample collection in comparison to the nasopharyngeal specimen
collection—an explanation that is no doubt, logical and valid.
Nonetheless, when we combine all the findings, it seems fair
to surmise that SARS-CoV-2 RNA
is consistently found in the saliva of both asymptomatic and symptomatic
patients.
While
reading this article, the statement that the level of Covid-19 RNA decreased
after the onset of symptom in both salivary and nasopharyngeal specimens caught
my attention and aroused my curiosity. A few search entries in google and I was
at the CDC website with exciting updates,
· Concentrations
of virus RNA in upper respiratory specimens declines after onset of symptoms.
https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html#key-findings
It seems that the safest bet is to treat patients who were
infected and recovered.
Considering we are now resigned that for the foreseeable future
the entire population remains at risk and an eventual infection is almost
inevitable, COVID -19 tests may become the first test, where testing positive
becomes a requirement before any treatment.
AND So it may come to pass that - Tis better to have had COVID & survived than to have never had it at all…
These are unprecedented times indeed!!
Good information madam
ReplyDeleteThank you for reading and commenting.
DeleteThank you mam, your article has shared optimistic experiences...thank u for valuable information
DeleteThank you for reading and commenting.
DeleteNice and interesting information mam which will be helpful.
ReplyDeleteThank you for reading and commenting.
DeleteUnprecedented times surely mam...You are right..
ReplyDeleteYes,indeed. Thank you for reading and commenting.
DeleteVery interesting and informative. Thanks
ReplyDeleteThank you Sir,
Delete